Cargando…
PEGylated AdipoRon derivatives improve glucose and lipid metabolism under insulinopenic and high-fat diet conditions
The pleiotropic actions of adiponectin in improving cell survival and metabolism have motivated the development of small-molecule therapeutic agents for treating diabetes and lipotoxicity. AdipoRon is a synthetic agonist of the adiponectin receptors, yet is limited by its poor solubility and bioavai...
Autores principales: | Onodera, Toshiharu, Ghazvini Zadeh, Ebrahim, Xu, Peng, Gordillo, Ruth, Guo, Zheng, Joffin, Nolwenn, Yu, Biao, Scherer, Philipp E., Li, Wen-hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327158/ https://www.ncbi.nlm.nih.gov/pubmed/34214600 http://dx.doi.org/10.1016/j.jlr.2021.100095 |
Ejemplares similares
-
AdipoRon may be benefit for atherosclerosis prevention
por: Esfahani, Maryam, et al.
Publicado: (2017) -
AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
por: Abou‐Samra, Michel, et al.
Publicado: (2020) -
Protective effects of AdipoRon on the liver of Huoyan goose fed a high-fat diet
por: Cao, Zhongzan, et al.
Publicado: (2022) -
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
por: Fang, Qian, et al.
Publicado: (2023) -
AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
por: Nigro, Ersilia, et al.
Publicado: (2021)